Interim analyses are evaluations of data conducted at intervals during a clinical trial, rather than waiting until the end of the study. These analyses are crucial in cancer research where early detection of treatment effects or adverse reactions can significantly impact patient outcomes. The primary goal is to assess the efficacy, safety, and overall benefit of the treatment being studied.